Latin America, Middle East and Africa Dietary Supplements Market Size to register 10.4% CAGR

10-05-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report LAMEA Dietary Supplements Market, published by KBV research, the LAMEA Dietary Supplements Market Size would witness market growth of 10.4% CAGR during the forecast period (2017-2023).

The Brazil market holds the largest market share in LAMEA Vitamins & Minerals Dietary Supplements Market by Country in 2016 and would continue to be a dominant market till 2023; growing at a CAGR of 8.8 % during the forecast period. The Argentina market is expected to witness a CAGR of 10.6% during (2017-2023) in LAMEA Botanicals Dietary Supplements Market. Additionally, The UAE market is expected to witness a CAGR of 11.4% during (2017-2023) in LAMEA Amino Acids Dietary Supplements Market.

The Adults market holds the largest market share in LAMEA Dietary Supplements Market by End User in 2016 and would continue to be a dominant market till 2023; growing at a CAGR of 9.6 % during the forecast period. The Children market is expected to witness a CAGR of 11% during (2017 - 2023). Additionally, The Pregnant Woman market is expected to witness highest CAGR of 12.7% during (2017-2023).

The Tablets & Capsules market holds the largest market share in Nigeria Dietary Supplements Market by Product in 2016 and would continue to be a dominant market till 2023. The Liquids market is expected to witness a CAGR of 12.5% during (2017-2023). Additionally, The Powder market would garner market size of $453.9million by 2023.

Full Report: https://www.kbvresearch.com/lamea-dietary-supplements-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the Latin America, Middle East and Africa Dietary Supplements Market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, The Carlyle Group, GlaxoSmithKline plc, Alticor (Amway), Glanbia, Plc. (Glanbia Nutritionals), Bayer AG, Archer Daniels Midland Company, E. I. Du Pont De Nemours and Company, Nutraceutics Inc., and Pfizer, Inc.